Fred Hutch, NIH experts outlined plan for COVID-19 vaccines
On May 11, 2020, in a perspective published by the journal Science, Dr. Larry Corey from the Fred…
Rice University COVID-19 research fund backed six new initiatives
On May 8, 2020, the Rice University COVID-19 Research Fund Oversight and Review Committee announced it had funded…
USPTO announced COVID-19 Prioritized Examination Pilot Program for small and micro entities
On May 8, 2020, the U.S. Patent and Trademark Office (USPTO) announced a new COVID-19 Prioritized Examination Pilot…
The FDA issued EUA for first antigen test to help in rapid detection of virus that causes COVID-19 in patients
On May 8, 2020, the U.S. Food and Drug Administration (FDA) issued the first emergency use authorization (EUA)…
RedHill Biopharma received FDA approval for COVID-19 clinical study with opaganib in the U.S.
On May 8, 2020, RedHill Biopharma announced the U.S. Food and Drug Administration (FDA) had approved its Investigational…
The CoVIg-19 Plasma Alliance was established
On May 8, 2020, the CoVIg-19 Plasma Alliance was announced, an unprecedented partnership of the world’s leading plasma…
AbbVie completed acquisition of Allergan for nearly $62 billion
On May 8, 2020, AbbVie announced it had completed its acquisition of Allergan following receipt of regulatory approval…
Biotechnology | COVID-19 | Life Science News | Nanotechnology | Pharmaceutical | Therapeutics | Vaccine
Entos Pharma partnered with Precision NanoSystems to enable scalable GMP manufacturing of Fusogenix DNA COVID-19 vaccine
On May 7, 2020, Entos Pharmaceuticals announced a partnership with PrecisionNanoSystems (PNI) to produce clinica lgrade vaccines and…
COVID-19 in-home monitoring program launched
On May 7, 2020, Washington University in St. Louis announced that people with COVID-19 who are seen by…
Royal DSM accelerated Dutch Covid-19 testing by making 28 million nose swabs
On May 7, 2020, Royal DSM announced it had started manufacturing nose swabs for the first time to…
Biotechnology | COVID-19 | Diagnostics | Genomics | Life Science News | Non-Profit Research | Therapeutics
Two groundbreaking drugs could combat COVID-19 and its deadliest symptoms
On May 7, 2020, City of Hope announced that two existing drugs using advanced genomic technology, were being…
OPTI Medical Systems received FDA Emergency Use Authorization for OPTI SARS-CoV-2 RNA PCR test kit for detection of Virus causing COVID-19
On May 7, 2020, OPTI Medical Systems, an IDEXX Laboratories subsidiary announced the U.S. Food and Drug Administration…
Mesoblast announced first patients dosed in phase 2/3 trial for COVID-19 ARDS
On May 6, 2020, Mesoblast announced that the first patients were dosed in the 300-patient randomized placebo-controlled Phase…
New freeze-resistant trichinella species discovered in wolverines
On May 6, 2020, the U.S. Dept. of Agriculture (USDA) announced that a new freeze-resistant Trichinella species had…
bioMerieux serology tests for SARS-CoV-2 on VIDAS underwent validation preceding launch
On May 6, 2020, bioMerieux announced performance validation and the launch of VIDAS anti-SARS-CoV-2 serology tests to detect…
Laurent Pharmaceuticals received Health Canada’s approval to initiate COVID-19 clinical trial
On May 6, 2020, Laurent Pharmaceuticals announced that it has obtained the approval from Health Canada to initiate…
U.S. Dept. of Veterans Affairs Airborne Hazards and Open Burn Pit Registry reached major milestone
On May 5, 2020, the U.S. Dept. of Veterans Affairs (VA) announced the Airborne Hazards and Open Burn…
FDA provided Emergency Use Authorization to PerkinElmer for serological test to identify COVID-19 antibodies
On May 5, 2020, PerkinElmer announced the FDA provided Emergency Use Authorization (EUA) for EUROIMMUN’s (a PerkinElmer company)…
LabCorp announced availability of COVID-19 antibody test
On May 5, 2020, LabCorp announced that its COVID-19 Immunoglobulin G (IgG) antibody test is now available for…
Biotechnology | COVID-19 | Diagnostics | Life Science News | Medical Device | Non-Profit Research | Pharmaceutical | Therapeutics
USPTO launched platform to facilitate connections between patent holders and potential licensees in key technologies
On May 4, 2020, the U.S. Patent and Trademark Office (USPTO) unveiled a new web-based intellectual property marketplace…
Biotechnology | COVID-19 | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics
Mayo Clinic received $26 million from BARDA for COVID-19 convalescent plasma expanded access program
On May 4, 2020, Mayo Clinic was awarded a $26 million contract from the Biomedical Advanced Research and…
DNA Genotek’s ORAcollect RNA kit included in EUA granted to Biocerna SARS-CoV-2 test
On May 4, 2020, DNA Genotek, a subsidiary of OraSure Technologies, announced that its ORAcollect RNA kit (OR-100)…
Roche’s COVID-19 antibody test received FDA Emergency Use Authorization and is available in markets accepting the CE mark
On May 2, 2020, Roche announced that the FDA has issued an Emergency Use Authorization for its new…
Gilead announced investigational antiviral remdesivir received FDA Emergency Use Authorization for treatment of COVID-19
On May 1, 2020, Gilead announced the FDA granted emergency use authorization (EUA) for the investigational antiviral remdesivir…
USC study showed Alzheimer’s gene triggers early breakdowns in the blood-brain barrier, predicting cognitive decline
On May 1, 2020, a University of Southern California (USC) study suggested that temporarily suppressing the body’s immune…
US Dept of Veterans Affairs participated in drug, plasma trials in fight against COVID-19
On May 1, 2020, the U.S. Dept. of Veterans Affairs (VA) announced participation in a series of clinical…
FDA approved DARZALEX FASPRO, a new subcutaneous formulation of Daratumumab in treatment of patients with Multiple Myeloma
On May 1, 2020, Janssen Pharma, a Johnson & Johnson company, announced the U.S. Food and Drug Administration…
Moderna and Lonza announced worldwide strategic collaboration to manufacture Moderna’s Vaccine (mRNA-1273) against novel Coronavirus
On May 1, 2020, Moderna and Lonza announced a 10-year strategic collaboration agreement to enable larger scale manufacture…
Medigen Vaccine Biologics SARS-CoV-2 qPCR kit obtained CE Marking and Taiwan MOHW’s approval of specific medical device’s manufacturing
On Apr. 30, 2020, Medigen Vaccine Biologics (MVB) received notice that its SARS-CoV-2 qPCR Kit had complied with…
Evotec Biologics announced collaboration with Ology Bioservices on antibodies against Coronavirus
On Apr. 29, 2020, Evotec announced that its Seattle-based subsidiary Just – Evotec Biologics has entered into a…